IBH (Innovation in Behavioral Health) Model

Analysis updated November 9, 2026

Strategic questions for your team

Does our specialty behavioral health practice currently serve at least 25 Medicaid beneficiaries per month with moderate-to-severe behavioral health conditions (e.g., major depressive disorder, bipolar disorder, opioid use disorder) at the outpatient level of care — the minimum threshold for Practice Participant eligibility — and are we licensed by the state and enrolled as a Medicaid provider in one of the three current participating states (Michigan, New York, or South Carolina) or a state likely to be selected under the Cohort II NOFO (up to 5 additional states, awards anticipated September 15, 2026, performance period January 1, 2027–December 31, 2033)?
Can our organization financially sustain a three-year pre-implementation period (2027–2028 for Cohort II) with no Integration Support Payment revenue before the implementation period begins in January 2029, and have we modeled the projected Medicare ISP cash flow of approximately $200–$220 per-member-per-month against our current payer mix, given that Medicare Advantage enrollees and commercially insured patients are explicitly excluded from IBH Model payments?
Do we have — or can we build within the pre-implementation period — the interprofessional care team infrastructure required by the IBH care delivery framework, specifically: a Physical Health Consultant (physician, NP, or PA) capable of advising on diabetes, hypertension, and tobacco use screening; care management staff to execute person-centered care plans; and community health workers or peer support specialists to manage closed-loop HRSN referrals?
What is our current health IT maturity — specifically, do we have a certified EHR with interoperability capability, and can we realistically qualify for and deploy up to $200,000 in CMS Medicare infrastructure funding (available to practices participating in both Medicaid and Medicare payment approaches) or the state-administered ~$100,000 set-aside (for Medicaid-only participants), based on a standardized practice needs assessment conducted during pre-implementation?
Are we enrolled as a fee-for-service Medicare provider in good standing with an up-to-date PECOS record and no outstanding fraud or abuse litigation — the prerequisite for accessing the Medicare payment arm of the model — and if not, what is our realistic timeline and cost to achieve Medicare enrollment before the Cohort II Implementation Period begins January 1, 2029?
How does IBH Model participation interact with our existing value-based payment arrangements — particularly any MSSP ACO participation, CCBHC demonstration enrollment, or Medicaid Health Home contracts — given that CMS has published a list of prohibited billing codes (Appendix XI of the NOFO) to prevent duplicate payment, and that CCBHC alignment requires state-by-state review of payment, infrastructure funding, and quality measure crosswalks during the pre-implementation period?
Can our organization meet the IBH Model's mandatory quality reporting requirements — including the five practice-based performance measures (tobacco use screening, ED utilization, controlling high blood pressure, screening for social drivers of health, and a patient-reported outcome measure) and the nine state-based measures (including follow-up after ED visit for SUD/mental illness, HbA1c control, and plan all-cause readmissions) — and do we have the data infrastructure to submit quarterly measure data to the state and CMS throughout the implementation period (2029–2033)?
What is our organization's risk tolerance for a payment model that requires progressing from LAN Category 2A (infrastructure-tied FFS) at model entry to at least LAN Category 2B by the start of Model Year 3 (BP3) and LAN Category 2C or above for select measures by Model Year 4 (BP4), meaning a portion of our revenue will shift from guaranteed per-visit FFS to performance-based payments tied to quality outcomes before we have accumulated sufficient implementation-period data?
Have we conducted a population health needs assessment of our Medicaid behavioral health panel — identifying prevalence of diabetes, hypertension, and tobacco use co-morbidities as well as food, housing, and transportation barriers — to determine whether our patient population's clinical profile and social complexity align with the IBH Model's theory of change (reducing avoidable ED visits and hospitalizations) in a way that could realistically generate the improved outcomes needed to earn performance-based payment incentives during the 2029–2033 implementation period?
What is our state Medicaid agency's current posture toward the IBH Model — have they applied for Cohort I (Michigan, New York, South Carolina were awarded January 1, 2025) or signaled intent to submit a Cohort II application by the June 3, 2026 deadline — and if our state has not engaged, what is our strategy to advocate for state participation given that Practice Participants have no independent pathway to apply directly to CMS and must be recruited through a participating state Medicaid agency?

Traps and concerns

Medicaid Payment Approach Deadline Compression Risk
State recipients (Cohort I) must finalize their Medicaid Payment Approach by the end of Model Year 2 (December 2026) for implementation at the start of Model Year 3 (January 2027). This requires states to secure all necessary federal authorities — state plan amendments, Section 1115 waivers, 1915 authorities, or Medicaid managed care contract modifications — within the pre-implementation window. For Cohort II recipients, this compressed to a two-year pre-implementation period (January 2027–December 2028) with payment live by January 2029. States that underestimate the CMS approval timeline for waiver authorities risk entering the implementation period without an approved Medicaid payment mechanism, leaving Practice Participants legally unable to receive IBH payments and potentially triggering participant attrition before services begin. The payment must progress from LAN Category 2A (infrastructure-tied FFS) at baseline, to 2B by MY3, to Category 2C or above for select measures by MY4 — each transition requiring regulatory infrastructure that cannot be improvised at the last minute.
Dual-Participation Revenue Disruption from Code Prohibition List
The NOFO explicitly prohibits Practice Participants from billing certain existing Medicare CPT/HCPCS codes when a beneficiary is attributed to the IBH Model — specifically to prevent duplication with the Integration Support Payment (ISP), which CMS has indicated will range approximately $200–$220 per-member-per-month. For practices currently billing Medicare Behavioral Health Integration (BHI) service codes or other care management codes, attribution of their existing Medicare patients to IBH will eliminate those revenue streams and replace them with the ISP. If a practice's existing BHI billing exceeds the IBH ISP for a given patient panel — possible for high-complexity panels — the net financial effect of model participation could be negative during the implementation period. Practices must conduct a CPT/HCPCS crosswalk analysis (referenced in Section A4.3.3 as a Recipient obligation) before committing to participation, and states that fail to facilitate this analysis during recruitment expose Practice Participants to unexpected revenue loss upon ISP activation in MY4/MY3 (Cohort I/II respectively).
42 CFR Part 2 SUD Data Sharing Compliance Barrier
The IBH Model requires closed-loop referrals, interprofessional care team communication, and real-time data sharing across behavioral health, physical health, and community-based organizations. However, the NOFO explicitly acknowledges that 42 C.F.R. Part 2 — which governs confidentiality of SUD treatment records — prohibits certain disclosures of SUD patient information without explicit patient consent, even within care teams. For Practice Participants serving populations with substance use disorders (a core target population for IBH), this creates a structural compliance barrier: the care integration model depends on information flow that Part 2 may legally restrict. States and Practice Participants must design consent workflows, re-disclosure protections, and health IT configurations that satisfy both HIPAA and Part 2 simultaneously. Practices operating EHRs not yet configured for Part 2-compliant segmented sharing face both compliance exposure and the practical inability to fulfill required care management functions, potentially disqualifying attributed SUD patients from receiving the full IBH care delivery framework — undermining both quality measure performance and ISP justification.
Practice-Level EHR Infrastructure Deficit Exceeding Funding Caps
CMS will provide up to $200,000 in total infrastructure funding for Practice Participants participating in both Medicaid and Medicare payment approaches, distributed over multiple years based on a standardized practice needs assessment. State cooperative agreement funds — capped at $7.5 million per state over the full performance period — must cover approximately $100,000 per Medicaid-only Practice Participant for infrastructure. For states with large practice recruitment targets (CMS anticipates approximately 10,000 Medicaid beneficiaries with MSBH conditions per state, implying potentially dozens of Practice Participants), the $7.5M cooperative agreement may be substantially consumed by infrastructure set-asides alone, leaving limited funds for state-level operations, convening, data reporting, and technical assistance. Moreover, specialty behavioral health providers — unlike primary care counterparts — were excluded from HITECH Act EHR incentive payments and often operate on legacy or non-certified EHR systems. The gap between actual health IT modernization costs and the available $100,000–$200,000 infrastructure cap may be substantial for smaller community mental health centers, OTPs, and tribal providers, forcing them to either absorb costs or deliver the care framework without adequate interoperability infrastructure, directly compromising quality measure reporting and closed-loop referral execution.
Medicare Attribution Conflict with Concurrent ACO/MSSP Models
The NOFO references that Practice Participants will receive quarterly prospective attribution lists for Medicare and dually eligible beneficiaries, but office hour transcripts confirm that CMS had not yet finalized its policy on attribution conflicts when beneficiaries are simultaneously attributed to IBH and another Medicare model (e.g., MSSP ACO, REACH ACO, or Primary Care First). A question raised by a participant on July 25, 2024 about whether IBH attribution would conflict with MSSP attribution was explicitly deferred without a definitive answer. For Practice Participants whose attributed Medicare patients are also assigned to ACOs receiving shared savings, duplicate attribution creates both a payment integrity risk (CMS overpayment exposure) and an operational burden (competing care management protocols, quality measure sets, and reporting obligations). Practices in states with high ACO penetration — including Cohort I states Michigan, New York, and South Carolina — face the highest risk that a meaningful portion of their prospectively attributed IBH Medicare panel may be simultaneously assigned to other risk-bearing entities, triggering recoupment or reconciliation adjustments that erode the financial viability of the $200–$220 PMPM ISP.
MCO Contract Modification Timeline and Medicaid FFS Eligibility Gate
Only states delivering Medicaid services through fee-for-service OR through managed care organizations are eligible — but states using MCOs must secure Letters of Intent from at least one MCO, PIHP, or PAHP as a condition of the NOFO application, and must subsequently execute Medicaid managed care contract modifications to operationalize IBH payments through the managed care system. For Cohort II, this LOI is required at application submission (due June 3, 2026), meaning states must have pre-negotiated MCO alignment before awards are even issued (anticipated September 15, 2026). MCOs that are contractually unwilling to accept a new per-member-per-month payment obligation for attributed behavioral health members — or that demand capitation rate adjustments from the state actuaries to absorb IBH payment requirements — can block implementation entirely for managed care states. In states like New York and South Carolina where Medicaid behavioral health is predominantly managed care-delivered, a single non-cooperative MCO can effectively exclude large geographic regions of Practice Participants from participation, undermining recruitment targets and threatening the minimum 25-Medicaid-MSBH-beneficiary-per-month threshold required for each Practice Participant's continued eligibility.
Performance-Based Payment Quality Measure Readiness Gap
Beginning in the Implementation Period (MY4/MY3 for Cohort I/II), Practice Participants become subject to performance-based payments (PBP) tied to a defined quality measure set that includes tobacco use screening and cessation intervention, controlling high blood pressure, emergency department utilization, screening for social drivers of health, and patient-reported outcome measures (PROMs). State-level measures include follow-up after ED visit for substance use, follow-up after hospitalization for mental illness, hemoglobin A1c control, diabetes screening for antipsychotic medication users, and plan all-cause readmissions — all requiring data collection systems, interoperability with hospital discharge data, and claims analytics that most specialty behavioral health practices do not currently have in place. Practices that fail to achieve reporting readiness by the start of the performance-based payment period will forfeit pay-for-reporting bonuses (expressed as a percentage of the ISP) and subsequently pay-for-performance incentives. Given that the ISP itself is the primary new revenue stream (estimated $200–$220 PMPM) and PBP bonuses are calculated as a percentage of that payment increasing over time, the compounding financial cost of quality infrastructure failure — lost reporting bonuses plus lost performance bonuses — could eliminate the economic case for model participation precisely when practices have already invested pre-implementation period resources in transformation activities.